Resources
FEATURED VIDEO
Revolutionizing Metabolomics
Enhanced LC-MS Annotation using Pyxis
News & Press Releases
DECEMBER 2024 |
Pyxis™ Receives The Analytical Scientist Innovation Award 2024Matterworks receives The Analytical Scientist Innovation Award 2024 for Pyxis, a "smart application of AI for the analysis of LC-MS data." |
JUNE 2024 |
Matterworks Launches Pyxis™ - First AI-Powered, Turn-Key Platform for Identification and Absolute Quantitation from Mass Spectrometry DataMatterworks is pleased to announce the official launch of Pyxis, our AI-powered platform for untargeted absolute quantitation of analytes. |
MAY 2024 |
Matterworks Announces Updates to Leadership TeamMatterworks is pleased to announce the appointments of Jennifer M. Campbell, Ph.D. to the position of Chief Scientific Officer and Niall O'Connor to the position of Chief Technology Officer. |
FEBRUARY 2024 |
Matterworks Announces Board UpdatesMatterworks is pleased to announce the appointments of Michael Lavin, a Managing Partner at Germin8 Ventures and Dr. Shubhra Jain, Head of Health-Tech Venture Investments at Tarsadia, as Board Members. |
MARCH 2023 |
2023 Life Science Review AwardMatterworks has been recognized in the Top 10 Biotech Startups - 2023 by Life Science Review. |
DECEMBER 2022 |
Matterworks Announces CEO Appointment and Board UpdatesMatterworks, Inc., developers of the world’s most powerful AI platform for modeling real-time biology to accelerate the discovery, development, and manufacturing of life sciences technologies, including biologics and gene therapies, today announces CEO appointment and updates to its Board of Directors. |
AUGUST 2022 |
Matterworks Awarded NIIMBL Project 5.2 GrantMatterworks is awarded a grant to participate in NIIMBL Project 5.2. With support from Eli Lilly and Sartorius our novel AI-powered Pyxis™ Metabolomics Platform will demonstrate biological insight in bioprocessing through the rapid, absolute quantitation of critical metabolites that impact titer and CQAs. |
APRIL 2022 |
Matterworks Announces Updates To Its Board Of DirectorsMatterworks, Inc., developers of the world’s most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors. |
Product Literature

Preprint: LSM1-MS2: A Foundation Model for MS/MS, Encompassing Chemical Property Predictions and de novo Generation
Read our preprint about Matterworks' LSM1-MS2, a pre-trained self-supervised foundation model for tandem mass spectrometry (MS/MS).

Revolutionizing Metabolomics: AI Meets Mass Spectrometry
Download an editorial summary about our webinar hosted by The Analytical Scientist featuring Matterworks CSO Jennifer Campbell and Dr. Naama Kanarek.

Preprint: A scalable approach to absolute quantitation in metabolomics
Read our preprint authored in conjunction with collaborators from Boston Children's Hospital and Harvard Medical School.

Using Pyxis for the Characterization of Microbiome Function
An application brief explaining how Pyxis can be used for absolute quantitation of untargeted small-molecule messenger analytes to elucidate microbiome function.

Infographic: Navigate Your Way to Precise and Scalable Untargeted Metabolomics
An infographic that highlights the advantages of absolute quantitation over relative quantitation and explains how Pyxis enables absolute quantitation.

High Throughput Metabolite Quantification in Biological Samples with Pyxis, a Matrix-Agnostic AI/ML Tool
A poster authored by Sofia Costa, PhD, Principal Scientist at Matterworks. Presented at Metabolomics Association of North America (MANA) 2024.